United States Covid-19 Vaccine Market Report & Forecast 2021-2027

Publisher Name :
Date: 13-Sep-2021
No. of pages: 93
Inquire Before Buying

United States Covid-19 Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Covid-19 Vaccine Market Segment Percentages, By Type, 2020 (%)

- DNA

- Non-replicating Viral Vector

- Protein Subunit

- RNA

- Others

United States Covid-19 Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Covid-19 Vaccine Market Segment Percentages, By Application, 2020 (%)

- Adults

- Children

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Covid-19 Vaccine revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Covid-19 Vaccine revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Moderna

- CanSino Biologicals

- Inovio Pharmaceuticals

- Shenzhen Geno-Immune Medical Institute

- GlaxoSmithKine

- Pfizer

- Johnson?Johnson

- Heat Biologics

- Sanofi

United States Covid-19 Vaccine Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Covid-19 Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Covid-19 Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Covid-19 Vaccine Overall Market Size
2.1 United States Covid-19 Vaccine Market Size: 2021 VS 2027
2.2 United States Covid-19 Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Covid-19 Vaccine Players in United States Market
3.2 Top United States Covid-19 Vaccine Companies Ranked by Revenue
3.3 United States Covid-19 Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Covid-19 Vaccine Companies in United States Market, by Revenue in 2020
3.5 Companies Covid-19 Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Covid-19 Vaccine Players in United States Market
3.6.1 List of Tier 1 Covid-19 Vaccine Companies in United States
3.6.2 List of Tier 2 and Tier 3 Covid-19 Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Covid-19 Vaccine Market Size Markets, 2021 & 2027
4.1.2 DNA
4.1.3 Non-replicating Viral Vector
4.1.4 Protein Subunit
4.1.5 RNA
4.1.6 Others
4.2 By Type - United States Covid-19 Vaccine Revenue & Forecasts
4.2.1 By Type - United States Covid-19 Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Covid-19 Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Covid-19 Vaccine Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Covid-19 Vaccine Market Size, 2021 & 2027
5.1.2 Adults
5.1.3 Children
5.2 By Application - United States Covid-19 Vaccine Revenue & Forecasts
5.2.1 By Application - United States Covid-19 Vaccine Revenue, 2016-2021
5.2.2 By Application - United States Covid-19 Vaccine Revenue, 2022-2027
5.2.3 By Application - United States Covid-19 Vaccine Revenue Market Share, 2016-2027
6 Covid-19 Vaccine Companies Profiles
6.1 Moderna
6.1.1 Moderna Company Details
6.1.2 Moderna Business Overview
6.1.3 Moderna Covid-19 Vaccine Introduction
6.1.4 Moderna Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.1.5 Moderna Recent Developments
6.2 CanSino Biologicals
6.2.1 CanSino Biologicals Company Details
6.2.2 CanSino Biologicals Business Overview
6.2.3 CanSino Biologicals Covid-19 Vaccine Introduction
6.2.4 CanSino Biologicals Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.2.5 CanSino Biologicals Recent Developments
6.3 Inovio Pharmaceuticals
6.3.1 Inovio Pharmaceuticals Company Details
6.3.2 Inovio Pharmaceuticals Business Overview
6.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction
6.3.4 Inovio Pharmaceuticals Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.3.5 Inovio Pharmaceuticals Recent Developments
6.4 Shenzhen Geno-Immune Medical Institute
6.4.1 Shenzhen Geno-Immune Medical Institute Company Details
6.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
6.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Introduction
6.4.4 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments
6.5 GlaxoSmithKine
6.5.1 GlaxoSmithKine Company Details
6.5.2 GlaxoSmithKine Business Overview
6.5.3 GlaxoSmithKine Covid-19 Vaccine Introduction
6.5.4 GlaxoSmithKine Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.5.5 GlaxoSmithKine Recent Developments
6.6 Pfizer
6.6.1 Pfizer Company Details
6.6.2 Pfizer Business Overview
6.6.3 Pfizer Covid-19 Vaccine Introduction
6.6.4 Pfizer Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.6.5 Pfizer Recent Developments
6.7 Johnson?Johnson
6.7.1 Johnson?Johnson Company Details
6.7.2 Johnson?Johnson Business Overview
6.7.3 Johnson?Johnson Covid-19 Vaccine Introduction
6.7.4 Johnson?Johnson Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.7.5 Johnson?Johnson Recent Developments
6.8 Heat Biologics
6.8.1 Heat Biologics Company Details
6.8.2 Heat Biologics Business Overview
6.8.3 Heat Biologics Covid-19 Vaccine Introduction
6.8.4 Heat Biologics Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.8.5 Heat Biologics Recent Developments
6.9 Sanofi
6.9.1 Sanofi Company Details
6.9.2 Sanofi Business Overview
6.9.3 Sanofi Covid-19 Vaccine Introduction
6.9.4 Sanofi Covid-19 Vaccine Revenue in United States Market (2016-2021)
6.9.5 Sanofi Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Covid-19 Vaccine Market Opportunities & Trends in United States Market
Table 2. Covid-19 Vaccine Market Drivers in United States Market
Table 3. Covid-19 Vaccine Market Restraints in United States Market
Table 4. Key Players of Covid-19 Vaccine in United States Market
Table 5. Top Covid-19 Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Covid-19 Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Covid-19 Vaccine Revenue Share by Companies, 2016-2021
Table 8. Companies Covid-19 Vaccine Product Type
Table 9. List of Tier 1 Covid-19 Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Covid-19 Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Covid-19 Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Covid-19 Vaccine Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Covid-19 Vaccine Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Covid-19 Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Covid-19 Vaccine Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Covid-19 Vaccine Revenue (US$, Mn), 2022-2027
Table 17. Moderna Company Details
Table 18. Moderna Business Overview
Table 19. Moderna Covid-19 Vaccine Product
Table 20. Moderna Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Moderna Recent Developments
Table 22. CanSino Biologicals Company Details
Table 23. CanSino Biologicals Business Overview
Table 24. CanSino Biologicals Covid-19 Vaccine Product
Table 25. CanSino Biologicals Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. CanSino Biologicals Recent Developments
Table 27. Inovio Pharmaceuticals Company Details
Table 28. Inovio Pharmaceuticals Business Overview
Table 29. Inovio Pharmaceuticals Covid-19 Vaccine Product
Table 30. Inovio Pharmaceuticals Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Inovio Pharmaceuticals Recent Developments
Table 32. Shenzhen Geno-Immune Medical Institute Company Details
Table 33. Shenzhen Geno-Immune Medical Institute Business Overview
Table 34. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product
Table 35. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Shenzhen Geno-Immune Medical Institute Recent Developments
Table 37. GlaxoSmithKine Company Details
Table 38. GlaxoSmithKine Business Overview
Table 39. GlaxoSmithKine Covid-19 Vaccine Product
Table 40. GlaxoSmithKine Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. GlaxoSmithKine Recent Developments
Table 42. Pfizer Company Details
Table 43. Pfizer Business Overview
Table 44. Pfizer Covid-19 Vaccine Product
Table 45. Pfizer Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Pfizer Recent Developments
Table 47. Johnson?Johnson Company Details
Table 48. Johnson?Johnson Business Overview
Table 49. Johnson?Johnson Covid-19 Vaccine Product
Table 50. Johnson?Johnson Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Johnson?Johnson Recent Developments
Table 52. Heat Biologics Company Details
Table 53. Heat Biologics Business Overview
Table 54. Heat Biologics Covid-19 Vaccine Product
Table 55. Heat Biologics Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Heat Biologics Recent Developments
Table 57. Sanofi Company Details
Table 58. Sanofi Business Overview
Table 59. Sanofi Covid-19 Vaccine Product
Table 60. Sanofi Covid-19 Vaccine Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Sanofi Recent Developments
List of Figures
Figure 1. Covid-19 Vaccine Segment by Type
Figure 2. Covid-19 Vaccine Segment by Application
Figure 3. United States Covid-19 Vaccine Market Overview: 2020
Figure 4. United States Covid-19 Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Covid-19 Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Covid-19 Vaccine Revenue in 2020
Figure 7. By Type - United States Covid-19 Vaccine Revenue Market Share, 2016-2027
Figure 8. By Application - United States Covid-19 Vaccine Revenue Market Share, 2016-2027
Figure 9. Moderna Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. CanSino Biologicals Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Inovio Pharmaceuticals Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. GlaxoSmithKine Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Pfizer Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Johnson?Johnson Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Heat Biologics Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Sanofi Covid-19 Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs